journal article·2024-11Open access

Engineered Macrophage Membrane‐Coated S100A9‐siRNA for Ameliorating Myocardial Ischemia‐Reperfusion Injury

He Lu, Junzhuo Wang, Ziwei Chen, Jing Wang, Yaohui Jiang, Zequn Xia, Ya Hou, Pingping Shang, Rutian Li, Yuyong Liu, Jun Xie

Advanced Science· Volume 11· Issue 41

Abstract

Abstract Despite the widespread adoption of emergency coronary reperfusion therapy, reperfusion‐induced myocardial injury remains a challenging issue in clinical practice. Following myocardial reperfusion, S100A8/A9 molecules are considered pivotal in initiating and regulating tissue inflammatory damage. Effectively reducing the S100A8/A9 level in ischemic myocardial tissue holds significant therapeutic value in salvaging damaged myocardium. In this study, HA (hemagglutinin)‐ and RAGE (receptor for advanced glycation end products)‐ comodified macrophage membrane‐coated siRNA nanoparticles (MMM/RNA NPs) with siRNA targeting S100A9 (S100A9‐siRNA) are successfully prepared. This nanocarrier system is able to target effectively the injured myocardium in an inflammatory environment while evading digestive damage by lysosomes. In vivo, migration of MMM/RNA NPs to myocardial injury lesions is confirmed in a myocardial ischemia‐reperfusion injury (MIRI) mouse model. Intravenous injection of MMM/RNA NPs significantly reduced S100A9 levels in serum and myocardial tissues, further decreasing myocardial infarction area and improving cardiac function. Targeted reduction of S100A8/A9 by genetically modified macrophage membrane‐coated nanoparticles may represent a new therapeutic intervention for MIRI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: S100 Proteins and Annexins · Cardiac Ischemia and Reperfusion · Acute Kidney Injury Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nanjing Drum Tower Hospital Drum Tower Clinical College Nanjing University of Chinese Medicine No. 321 Zhongshan Road Nanjing 210008 China

Department of Cardiology Affiliated Hospital of Nantong University Nantong 226001 China

Nanjing Drum Tower Hospital Affiliated Hospital of Medical School Nanjing University No. 321 Zhongshan Road Nanjing 210008 China

Department of Cardiology The People's Hospital of Jiawang District of Xuzhou Xuzhou 221011 China

Department of Oncology Nanjing Drum Tower Hospital Affiliated Hospital of Medical School Nanjing University No. 321 Zhongshan Road Nanjing 210008 China

Department of Cardiac Surgery National Cardiovascular Disease Regional Center for Anhui the First Affiliated Hospital of Anhui Medical University Hefei 230022 China

Beijing Institute of Heart Lung, and Blood Vessel Diseases Beijing Anzhen Hospital Affiliated to Capital Medical University Beijing 100029 China

Funding

National Natural Science Foundation of China

References (48)

Show source-provided references
1. 10.1056/NEJMra07166710.1056/NEJMra071667 ↗
2. 10.1016/j.biomaterials.2023.12236810.1016/j.biomaterials.2023.122368 ↗
3. 10.1161/CIRCRESAHA.117.31132710.1161/CIRCRESAHA.117.311327 ↗
4. 10.1161/01.CIR.0000112575.66565.8410.1161/01.CIR.0000112575.66565.84 ↗
5. 10.1161/CIRCULATIONAHA.122.06025710.1161/CIRCULATIONAHA.122.060257 ↗
6. 10.3390/ijms2216884510.3390/ijms22168845 ↗
7. 10.1128/MCB.23.3.1034-1043.200310.1128/MCB.23.3.1034-1043.2003 ↗
8. 10.1161/CIRCULATIONAHA.118.03926210.1161/CIRCULATIONAHA.118.039262 ↗
9. 10.1161/CIRCULATIONAHA.119.04383310.1161/CIRCULATIONAHA.119.043833 ↗
10. 10.1126/sciadv.abf739010.1126/sciadv.abf7390 ↗
11. 10.1073/pnas.170191111410.1073/pnas.1701911114 ↗
12. 10.1038/nature0895610.1038/nature08956 ↗
13. 10.1021/acs.accounts.9b0036810.1021/acs.accounts.9b00368 ↗
14. 10.1021/ja400986u10.1021/ja400986u ↗
15. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
16. 10.1002/adma.20180574010.1002/adma.201805740 ↗
17. 10.1021/acsami.6b0085310.1021/acsami.6b00853 ↗
18. 10.1021/acsnano.6b0314810.1021/acsnano.6b03148 ↗
19. 10.1002/adhm.20150012910.1002/adhm.201500129 ↗
20. 10.1002/adma.20150608610.1002/adma.201506086 ↗
21. 10.1016/j.jconrel.2015.07.01910.1016/j.jconrel.2015.07.019 ↗
22. 10.1002/adma.20200180810.1002/adma.202001808 ↗
23. 10.1126/sciadv.abf782010.1126/sciadv.abf7820 ↗
24. Yin C. · Innovation · 2023 · 4
25. 10.1021/acsnano.0c0032610.1021/acsnano.0c00326 ↗
26. 10.1016/j.addr.2023.11486510.1016/j.addr.2023.114865 ↗
27. Shen Z. · Innovation · 2024 · 5
28. Xie L. · Innovation · 2021 · 2
29. 10.1016/j.bioactmat.2022.01.02610.1016/j.bioactmat.2022.01.026 ↗
30. 10.1016/j.tim.2018.03.00510.1016/j.tim.2018.03.005 ↗
31. 10.1146/annurev-biophys-070317-03301810.1146/annurev-biophys-070317-033018 ↗
32. 10.1002/smll.20170349310.1002/smll.201703493 ↗
33. 10.7150/thno.4784110.7150/thno.47841 ↗
34. 10.1002/adhm.20210178810.1002/adhm.202101788 ↗
35. 10.1073/pnas.171426711410.1073/pnas.1714267114 ↗
36. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
37. 10.1016/j.bioactmat.2022.11.01610.1016/j.bioactmat.2022.11.016 ↗
38. 10.1128/mSphere.00335-1710.1128/mSphere.00335-17 ↗
39. 10.1038/nnano.2013.5410.1038/nnano.2013.54 ↗
40. 10.1002/btm2.1019710.1002/btm2.10197 ↗
41. 10.1002/anie.20211367110.1002/anie.202113671 ↗
42. 10.1038/s41467-018-07741-610.1038/s41467-018-07741-6 ↗
43. 10.1007/s12010-010-9104-z10.1007/s12010-010-9104-z ↗
44. 10.1038/s41401-020-00606-z10.1038/s41401-020-00606-z ↗
45. 10.1002/advs.20220035310.1002/advs.202200353 ↗
46. 10.1021/acsnano.6b0824410.1021/acsnano.6b08244 ↗
47. 10.1021/acsnano.6b0604010.1021/acsnano.6b06040 ↗
48. 10.1161/HYPERTENSIONAHA.113.0284310.1161/HYPERTENSIONAHA.113.02843 ↗